Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

InspireMD (NSPR) EBIAT (2016 - 2025)

InspireMD's EBIAT history spans 16 years, with the latest figure at -$11.8 million for Q4 2025.

  • For Q4 2025, EBIAT fell 28.2% year-over-year to -$11.8 million; the TTM value through Dec 2025 reached -$48.8 million, down 52.43%, while the annual FY2025 figure was -$48.8 million, 52.43% down from the prior year.
  • EBIAT reached -$11.8 million in Q4 2025 per NSPR's latest filing, up from -$12.7 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$3.2 million in Q1 2021 to a low of -$13.2 million in Q2 2025.
  • Average EBIAT over 5 years is -$6.7 million, with a median of -$5.1 million recorded in 2023.
  • Peak YoY movement for EBIAT: crashed 82.31% in 2021, then increased 5.02% in 2023.
  • A 5-year view of EBIAT shows it stood at -$4.1 million in 2021, then fell by 18.26% to -$4.8 million in 2022, then fell by 11.56% to -$5.4 million in 2023, then tumbled by 69.73% to -$9.2 million in 2024, then decreased by 28.2% to -$11.8 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's EBIAT are -$11.8 million (Q4 2025), -$12.7 million (Q3 2025), and -$13.2 million (Q2 2025).